Search research articles
Contact Us
Filters
Showing results (481-490 of 574) with videos related to
Page
of 58
Sort By:
Nature Communications
|
December 3, 2024
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer
Lisa Veghini, Davide Pasini, Rui Fang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 2, 2024
SWI/SNF Complex-Deficient Undifferentiated Carcinoma of the Pancreas: Clinicopathologic and Genomic Analysis
Aslihan Yavas, Kerem Ozcan, N Volkan Adsay, et al.
Annals of Surgery
|
December 1, 2017
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution
Luca Landoni, Giovanni Marchegiani, Tommaso Pollini, et al.
Endocrine Pathology
|
May 10, 2025
Clinicopathological Correlates of Hormone Expression-Based Subtypes of Non-Functioning Duodenal/Ampullary Neuroendocrine Tumors: A Multicenter Study of 151 Cases
Alessandro Vanoli, Nestor Piva, Frediano Socrate Inzani, et al.
Journal of Neuroendocrinology
|
December 14, 2023
Use and perceived utility of [<sup>18</sup> F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022
Valentina Ambrosini, Martyn Caplin, Justo P Castaño, et al.
Annals of Surgery
|
February 6, 2023
The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer
Stephan B Dreyer, Sarah Rae, Kirsty Bisset, et al.
Immunity
|
May 15, 2024
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer
Francesco De Sanctis, Silvia Dusi, Simone Caligola, et al.
Oncogene
|
August 13, 2022
Loss of FGFR4 promotes the malignant phenotype of PDAC
Sabrina D'Agosto, Francesco Pezzini, Lisa Veghini, et al.
Gastroenterology
|
September 1, 2016
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice
Pouria Jandaghi, Hamed S Najafabadi, Andrea S Bauer, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct expression patterns and potential markers of progression
Yuefan Wang, T Mamie Lih, Jae W Lee, et al.
Page
of 58
Search research articles
Search
Showing results (481-490 of 574) with videos related to
Sort By:
Page
of 58
Nature Communications
|
December 3, 2024
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer
Lisa Veghini, Davide Pasini, Rui Fang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 2, 2024
SWI/SNF Complex-Deficient Undifferentiated Carcinoma of the Pancreas: Clinicopathologic and Genomic Analysis
Aslihan Yavas, Kerem Ozcan, N Volkan Adsay, et al.
Annals of Surgery
|
December 1, 2017
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution
Luca Landoni, Giovanni Marchegiani, Tommaso Pollini, et al.
Endocrine Pathology
|
May 10, 2025
Clinicopathological Correlates of Hormone Expression-Based Subtypes of Non-Functioning Duodenal/Ampullary Neuroendocrine Tumors: A Multicenter Study of 151 Cases
Alessandro Vanoli, Nestor Piva, Frediano Socrate Inzani, et al.
Journal of Neuroendocrinology
|
December 14, 2023
Use and perceived utility of [<sup>18</sup> F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022
Valentina Ambrosini, Martyn Caplin, Justo P Castaño, et al.
Annals of Surgery
|
February 6, 2023
The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer
Stephan B Dreyer, Sarah Rae, Kirsty Bisset, et al.
Immunity
|
May 15, 2024
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer
Francesco De Sanctis, Silvia Dusi, Simone Caligola, et al.
Oncogene
|
August 13, 2022
Loss of FGFR4 promotes the malignant phenotype of PDAC
Sabrina D'Agosto, Francesco Pezzini, Lisa Veghini, et al.
Gastroenterology
|
September 1, 2016
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice
Pouria Jandaghi, Hamed S Najafabadi, Andrea S Bauer, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct expression patterns and potential markers of progression
Yuefan Wang, T Mamie Lih, Jae W Lee, et al.
Page
of 58